title: Ximelagatran versus warfarin in the prevention of atrial fibrillation-related stroke: both sides of the story.
authors.forename: Luca
authors.initials: L
authors.lastname: Testa
authors.forename: William
authors.initials: W
authors.lastname: Van Gaal
authors.forename: Pierfrancesco
authors.initials: P
authors.lastname: Agostoni
authors.forename: Antonio
authors.initials: A
authors.lastname: Abbate
authors.forename: Graziana
authors.initials: G
authors.lastname: Trotta
authors.forename: Giuseppe G L
authors.initials: GG
authors.lastname: Biondi-Zoccai
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications*; D001384:Azetidines / Q000627:therapeutic use*; D001596:Benzylamines / Q000627:therapeutic use*; D006801:Humans; D020521:Stroke / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control; D014859:Warfarin / Q000627:therapeutic use*
chemical_list: D000925:Anticoagulants; D001384:Azetidines; D001596:Benzylamines; C426686:ximelagatran; D014859:Warfarin